Knowledge Hub
Dr. R. Brahmananda Reddy
6 April 2026

For centuries, medicine has asked one question: How do we help people live longer? And by that measure, we have succeeded spectacularly. Global life expectancy has more than doubled in the past 150 years. But somewhere along the way, we forgot to ask the more important question: How do we help people live well for longer?
This is the difference between lifespan — the total number of years you are alive — and healthspan — the number of years you spend in good health, free from chronic disease and disability.
Here is the uncomfortable reality: in most developed countries, the average person spends their last 12-15 years living with significant chronic disease or disability. In India, where the burden of metabolic and cardiovascular disease is particularly high, this number may be even worse.
A 2019 analysis in The Lancet using Global Burden of Disease data found that while life expectancy in India increased by 7.3 years between 1990 and 2019, healthy life expectancy increased by only 5.9 years. The gap is growing, not shrinking.
We are adding years to life without adding life to years.
Healthspan is determined by the onset of the four major chronic diseases that dominate modern morbidity and mortality: cardiovascular disease, cancer, neurodegenerative disease, and metabolic disease (including type 2 diabetes). The longer you can delay the onset of these conditions, the longer your healthspan.
The critical insight is that these diseases share common biological roots — the very hallmarks of aging we discussed elsewhere. Inflammation, insulin resistance, mitochondrial dysfunction, and cellular senescence contribute to all four. Address the shared biology, and you can compress morbidity across the board.
The ideal scenario is what researchers call compression of morbidity: pushing the onset of chronic disease as close to the end of life as possible. Instead of a slow, 15-year decline, the goal is to maintain high function until very late in life, followed by a rapid, brief decline.
This is not fantasy. Studies of centenarians — people who live past 100 — show that many of them exhibit exactly this pattern. They do not avoid disease entirely; they delay it by decades. Supercentenarians often spend only a few years in poor health before death, compared to the 12-15 years typical of the general population.
You cannot manage what you cannot measure. Healthspan metrics include grip strength, walking speed, balance, VO2 max, cognitive function tests, body composition, and a comprehensive panel of metabolic, inflammatory, and hormonal biomarkers.
At GenoRyx, our longevity assessments are designed to measure not just disease risk, but functional capacity — the markers that tell us whether you will still be climbing stairs, carrying groceries, and thinking clearly at 85. Book a consultation and let us help you build a plan that maximizes not just your years, but your quality of life within those years.
Book your 400+ biomarker assessment — physician consultation included.
Schedule a consultationReady to know your numbers?
Schedule your consultation with our longevity physician team.
Book Your AssessmentWritten by
UK-trained physician and founder of Genoryx. Writes about longevity medicine, healthspan optimization, and evidence-based wellness.
View profile →
Cold plunges, sauna sessions, fasting, and intense exercise all share one principle: brief, controlled stress triggers cellular repair pathways that make you more resilient.

Senescent zombie cells accumulate with age, refusing to die and poisoning their neighbours with inflammatory signals. Senolytic compounds can selectively clear them. Here is where the science stands in 2026.